InMode Ltd (INMD)

Add to Watchlists
Create an Alert
Quickflows
83.37 -1.81  -2.12% NASDAQ Oct 15, 16:00 83.38 +0.01  +0.01% After-Hours: 20:00 USD
View Full Chart
Price Chart
View All Key Stats

Key Stats

View All INMD News

News

View All Events

Events

Date Type Description
11/12/2021 Earnings Results Q3 2021 Earnings Results
11/12/2021 08:30 EST Earnings Calls Q3 2021 Earnings Call
10/01/2021 Splits 2 to 1 Split
07/28/2021 Earnings Results Q2 2021 Earnings Results
07/28/2021 08:30 EST Earnings Calls Q2 2021 Earnings Call
05/05/2021 Earnings Results Q1 2021 Earnings Results
05/05/2021 08:30 EST Earnings Calls Q1 2021 Earnings Call
04/05/2021 07:30 EST AGM 2020 Annual General Meeting
02/10/2021 Earnings Results Q4 2020 Earnings Results
02/10/2021 08:30 EST Earnings Calls Q4 2020 Earnings Call
View All Performance Charts

Total Returns Comparison

Fundamentals

Income Statement View Statement

Revenue (TTM) 287.75M
Total Expenses (TTM) 160.71M
Net Income (TTM) 127.58M

Balance Sheet View Statement

Total Assets (Quarterly) 383.03M
Total Liabilities (Quarterly) 51.86M
Shareholders Equity (Quarterly) 329.66M

Cash Flow Statement View Statement

Cash from Operations (TTM) 143.30M
Cash from Investing (TTM) -134.60M
Cash from Financing (TTM) -12.31M

Ratings & Reports

Advertisement
Edit

Profile

  • Description: InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its products platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, Evolve, Evoke, and Morpheus8. The majority of its revenue comes from the United States.
  • URL: https://www.inmodemd.com
  • Investor Relations URL: https://inmodemd.com/investors/
  • HQ State/Province: N/A
  • Sector: Healthcare
  • Industry: Medical Devices
  • Equity Style: N/A
  • Next Earnings Release: Nov. 12, 2021
  • Last Earnings Release: Jul. 28, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Analyst Coverage

Consensus Recommendations
Buy Recommendations Upgrade
Outperform Recommendations Upgrade
Hold Recommendations Upgrade
Underperform Recommendations Upgrade
Sell Recommendations Upgrade
Consensus Recommendation Upgrade
Consensus Rating Upgrade
Target Price
Price 83.37
Price Target Upgrade
Price Target Upside (Daily) Upgrade

Top Fund Holders

Symbol Name Weighting
ITEQ BlueStar Israel Technology ETF 4.27%
PNSBX Putnam Small Cap Growth B 4.17%
FFTY Innovator IBD® 50 ETF 3.91%
FPXI First Trust International Eq Opps ETF 3.28%
ALOYX Alger Mid Cap Focus Y 2.99%
GNSRX Aberdeen US Small Cap Equity R 2.83%
ISRA VanEck Israel ETF 2.53%
IZRL ARK Israel Innovative Technology ETF 2.20%
EIS iShares MSCI Israel ETF 2.11%
LADQX Lord Abbett Developing Growth R2 1.59%
AASMX Thrivent Small Cap Stock A 1.55%
MCISX Victory Trivalent International Sm-Cp C 0.78%

Comparables

Edit
APOP Cellect Biotechnology Ltd
AYLA Ayala Pharmaceuticals Inc
CANF Can Fite Biofarma Ltd
PHGE BiomX Inc
CGEN Compugen Ltd

Other Resources

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.